Addition of soluble clustered ligand abrogated these effects supporting a hypothesis that over-expression of EphB4 activates ligand-independent tumour promotion pathways and that ephrin-B2 ligand stimulation is tumour suppressive. The gene discussed is EFNB2; the disease is neoplasm.